InjuryBoard Philadelphia Archives

• Blood Loss Drug Linked to Serious Injuries

  Jamie Sheller | March 31, 2006 10:04 AM | 0 Comments
  Category: FDA & Prescription Drugs

  Trasylol is a drug that is intended to prevent blood loss. It is often administered to patients undergoing cardiopulmonary bypass surgery. On February 8, 2006 the FDA issued a Public Health Advisory for Trasylol (aprotinin injection) after two observational studies reported a possible association with the administration of the drug, kidney failure and ischemic events (heart attack and...

• Dangerous Side Effects of Tequin

  Jamie Sheller | March 23, 2006 2:03 PM | 0 Comments
  Category: FDA & Prescription Drugs

  Bristol-Myers Squibb Co., has added warnings to the label for the antibiotic Tequin. The antibiotic is used to treat various infections, including pneumonia, bronchitis and kidney infections. Since the approval of Tequin in 1999, there have been cases of life-threatening events. The new labeling contains updated warnings reflecting information from continued reports of serious hypoglycemia...

• Concerns Raised By Use of Antipsychotics By Children

  Jamie Sheller | March 21, 2006 8:51 AM | 1 Comments
  Category: FDA & Prescription Drugs

  A recent study demonstrates that the use of antipsychotics in children has increased from about 8.6 out of every 1,000 children in the mid-1990's to almost 40 out of 1,000. Antipsychotics include drugs such as Zyprexa and Risperdal, which generally cost several dollars per pill. These drugs are heavily marketed by the drug companies. Increasingly, children are being prescribed antipsychotic...

• Plavix and Aspirin Combination Not Beneficial For Preventing Heart Attacks

  Jamie Sheller | March 14, 2006 9:13 AM | 0 Comments
  Category: FDA & Prescription Drugs

  The results of a new study show that a combination of Plavix and aspirin should not be used to prevent heart attacks in people without coronary artery disease. Plavix is a blood thinner made by Sanofi-Adventis SA. For people who have already suffered a heart attack, adding Plavix to aspirin cuts the risk of a second heart attack or death. The study was conducted to determine whether the...

• New Jersey Drug Companies May Be Sued There By Out-of-State Plaintiffs

  Jamie Sheller | March 10, 2006 10:28 AM | 1 Comments
  Category: FDA & Prescription Drugs

  According to the New Jersey Appellate Division, a out-of-state plaintiff may continue his product liability case against Hoffman-La Roche. In the case, Rowe v. Hoffman-La Roche, Mr. Rowe alleges that the acne drug Accutane, which is manufactured by Hoffman-La Roche, caused his depression and suicide attempt. A lower court had dismissed the suit because the plaintiff is from Michigan and under...

• Use of Some Antidepressants Linked to Lung Defects in Newborns

  Jamie Sheller | March 09, 2006 9:47 AM | 0 Comments
  Category: FDA & Prescription Drugs

  According to an article in the New England Journal of Medicine, selective serotonin-reuptake inhibitors (SSRI's) may be associated with Persistent Pulmonary Hypertension of the newborn (PPHN). A recently completed study revealed that maternal use of SSRI's late in the third trimester of pregnancy results in an increased risk of PPHN. SSRI's are a class of antidepressant drugs, and include...

• In Pennsylvania Driver Has No Right to Consult Counsel Before Blood Alcohol Content Test

  Jamie Sheller | March 03, 2006 10:37 AM | 0 Comments
  Category: Automobile Accidents

  In Commonwealth v. Ciccola, a three judge panel of the Pennsylvania Superior Court has held that a person does not have the right to consult counsel before submitting to a blood alcohol content test after an arrest for driving under the influence. The Court found that the test is similar to a search and seizure after a police officer finds probable cause. According to the Court, though...